Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.1M
-
Number of holders
-
274
-
Total 13F shares, excl. options
-
43.8M
-
Shares change
-
+565K
-
Total reported value, excl. options
-
$1.3B
-
Value change
-
+$18.3M
-
Put/Call ratio
-
0.42
-
Number of buys
-
103
-
Number of sells
-
-97
-
Price
-
$29.74
Significant Holders of AVANOS MEDICAL, INC. - Common Stock (AVNS) as of Q1 2023
297 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock as of Q1 2023.
AVANOS MEDICAL, INC. - Common Stock (AVNS) has 274 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.8M shares
of 46.1M outstanding shares and own 94.97% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.46M shares), VANGUARD GROUP INC (5.53M shares), DIMENSIONAL FUND ADVISORS LP (3.17M shares), RGM Capital, LLC (2.65M shares), Paradice Investment Management LLC (2.29M shares), STATE STREET CORP (2.02M shares), MACQUARIE GROUP LTD (1.99M shares), T. Rowe Price Investment Management, Inc. (1.24M shares), WESTWOOD HOLDINGS GROUP INC (1.01M shares), and GOLDMAN SACHS GROUP INC (977K shares).
This table shows the top 274 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.